Related Experiment Video
Updated: Sep 13, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
ABC-transporters: implications on drug resistance from microorganisms to human cancers
1Institute of Pathology, Humboldt-University Berlin, Charité Campus Mitte, Schumannstrasse 20/21, D-10117 Berlin, Germany. hermann.lage@charite.de
Abstract:
Resistance to chemotherapy is a common clinical problem in patients with infectious diseases as well as in patients with cancer. During treatment of infections or malignant tumors, the drug targets of prokaryotic or eukaryotic microorganisms and neoplastic cells are often found to be refractory to a variety of drugs that have different structures and functions. This phenomenon has been termed multidrug resistance (MDR). The mechanisms leading to MDR are frequently caused by trans-membrane xenobiotic transport molecules belonging to the superfamily of ATP-binding cassette (ABC) transporters. There is an urgent need to understand the structure-function relationships of these efflux pumps that underlie their transport mechanism and drug selectivity. This knowledge may allow the rational design of new drugs that can inhibit or circumvent the activity of these MDR transport molecules. Furthermore, the development of such chemosensitizing agents would help us learn more about the physiological functions and substrates of these pump proteins. This review will discuss the current state of knowledge of the functional and structural similarities among ABC-transporters in prokaryotic and eukaryotic cells and their impact on MDR.
Insights
Multidrug resistance (MDR) is a major challenge in treating infections and cancer. Understanding ATP-binding cassette (ABC) transporters
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) poses a significant clinical challenge in both infectious diseases and cancer treatment.
- Drug targets in microorganisms and cancer cells often exhibit refractoriness to structurally diverse drugs.
- This phenomenon, known as multidrug resistance (MDR), is frequently mediated by transmembrane xenobiotic transport proteins.
Purpose of the Study:
- To elucidate the structure-function relationships of ATP-binding cassette (ABC) transporters involved in MDR.
- To understand the transport mechanisms and drug selectivity of these efflux pumps.
- To explore the potential for rational drug design targeting MDR transport molecules.
Main Methods:
- Comparative analysis of functional and structural similarities of ABC-transporters.
- Review of existing knowledge on prokaryotic and eukaryotic ABC-transporter systems.
- Examination of the impact of ABC-transporter mechanisms on MDR.
Main Results:
- Identified common functional and structural features among ABC-transporters across different cell types.
- Highlighted the critical role of ABC transporters in mediating MDR.
- Discussed the implications of transporter mechanisms for drug resistance.
Conclusions:
- Understanding ABC-transporter structure-function is crucial for combating MDR.
- Knowledge of these efflux pumps can guide the development of novel chemosensitizing agents.
- Further research into ABC transporters will advance our understanding of drug resistance and cellular transport.
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Treatment Resistant Cancers
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
